CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-18 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion | +1,778 | 242,260 | ||
| 2021-02-18 | Nanavaty Maulik SVP & Pres, Neuromodulation | Shares withheld for taxes | −615 | $37.52 | $23K | 241,645 |
| 2021-02-18 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion · Deferred Stock Units | −1,778 | 5,337 | ||
| 2021-02-18 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion | +637 | 35,496 | ||
| 2021-02-18 | Monson Jonathan VP, Global Controller and CAO | Shares withheld for taxes | −224 | $37.52 | $8K | 35,272 |
| 2021-02-18 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion · Deferred Stock Units | −637 | 1,912 | ||
| 2021-02-18 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +2,816 | 135,817 | ||
| 2021-02-18 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes | −862 | $37.52 | $32K | 134,955 |
| 2021-02-18 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Deferred Stock Units | −2,816 | 8,450 | ||
| 2021-02-17 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Exercise or conversion | +32,353 | $7.47 | $242K | 104,398.99 |
| 2021-02-17 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2021-02-17 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Grant or award · Stock Option (Right to Buy) | +32,161 | 32,161 | ||
| 2021-02-17 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Exercise or conversion · Stock Option (Right to Buy) | −32,353 | 0 | ||
| 2021-02-17 | Sorenson John Bradley SVP, Manuf & Sup Chn | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2021-02-17 | Sorenson John Bradley SVP, Manuf & Sup Chn | Grant or award · Stock Option (Right to Buy) | +19,296 | 19,296 | ||
| 2021-02-17 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Restricted Stock Units | +6,333 | 6,333 | ||
| 2021-02-17 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Stock Option (Right to Buy) | +20,368 | 20,368 | ||
| 2021-02-17 | Ralls-Morrison Desiree SVP, GC and Corp Secretary | Grant or award · Restricted Stock Units | +8,666 | 8,666 | ||
| 2021-02-17 | Ralls-Morrison Desiree SVP, GC and Corp Secretary | Grant or award · Stock Option (Right to Buy) | +27,873 | 27,873 | ||
| 2021-02-17 | Pierce David A EVP Pres MedSurg | Grant or award · Restricted Stock Units | +13,333 | 13,333 |
Page 103 of 104 · 2,069 trades